fluconazole has been researched along with Fusariosis in 4 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Fusariosis: OPPORTUNISTIC INFECTIONS with the soil fungus FUSARIUM. Typically the infection is limited to the nail plate (ONYCHOMYCOSIS). The infection can however become systemic especially in an IMMUNOCOMPROMISED HOST (e.g., NEUTROPENIA) and results in cutaneous and subcutaneous lesions, fever, KERATITIS, and pulmonary infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fusarium species have emerged as an important human pathogen in skin disease, onychomycosis, keratitis and invasive disease." | 7.85 | Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis. ( Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G, 2017) |
| "Fusarium species have emerged as an important human pathogen in skin disease, onychomycosis, keratitis and invasive disease." | 3.85 | Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis. ( Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G, 2017) |
| "Onychomycosis caused by Fusarium spp." | 3.81 | Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients. ( Galletti, J; Grassi, FL; Kioshima-Cotica, ÉS; Negri, M; Svidzinski, TI, 2015) |
| "One patient developed Fusarium infection." | 1.40 | Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country. ( Adil, SN; Ali, N; Shaikh, MU, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosa, PD | 1 |
| Heidrich, D | 1 |
| Corrêa, C | 1 |
| Scroferneker, ML | 1 |
| Vettorato, G | 1 |
| Fuentefria, AM | 1 |
| Goldani, LZ | 1 |
| Ali, N | 1 |
| Adil, SN | 1 |
| Shaikh, MU | 1 |
| Galletti, J | 1 |
| Negri, M | 1 |
| Grassi, FL | 1 |
| Kioshima-Cotica, ÉS | 1 |
| Svidzinski, TI | 1 |
| Dabas, Y | 1 |
| Bakhshi, S | 1 |
| Xess, I | 1 |
1 review available for fluconazole and Fusariosis
| Article | Year |
|---|---|
Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature.
Topics: Adolescent; Aged; Amphotericin B; Antifungal Agents; Base Sequence; DNA, Intergenic; Fluconazole; Fu | 2016 |
3 other studies available for fluconazole and Fusariosis
| Article | Year |
|---|---|
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Hum | 2017 |
Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Bacteremia; Candida albicans; Candidiasis; Cath | 2014 |
Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients.
Topics: Antifungal Agents; Cross-Sectional Studies; Fluconazole; Fusariosis; Fusarium; Humans; Keratins; Mic | 2015 |